G L Irish1,2, S Jesudason1,2. 1. Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia. 2. Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia.
Abstract
BACKGROUND: Tacrolimus has been used in pregnant women following transplantation and for management of lupus nephritis. We report a case of successful control of nephrotic syndrome due to membranous glomerulonephritis during pregnancy using tacrolimus. CASE REPORT: A 26-year-old female presented with severe nephrotic syndrome in her first pregnancy. Post-partum renal biopsy confirmed idiopathic membranous glomerulonephritis. She had persistent proteinuria of 6 g/day with hypoalbuminaemia despite angiotensin receptor blockade. Treatment with tacrolimus monotherapy led to remission of proteinuria, three months prior to conceiving again. She maintained remission with tacrolimus therapy in pregnancy, resulting in a successful birth outcome. CONCLUSIONS: Membranous glomerulonephritis can be successfully and safely managed with tacrolimus monotherapy during pregnancy. This provides an alternative immunosuppressant with a favourable side effect profile suitable for use in women planning a pregnancy when other immunosuppressive drugs should be avoided.
BACKGROUND: Tacrolimus has been used in pregnant women following transplantation and for management of lupus nephritis. We report a case of successful control of nephrotic syndrome due to membranous glomerulonephritis during pregnancy using tacrolimus. CASE REPORT: A 26-year-old female presented with severe nephrotic syndrome in her first pregnancy. Post-partum renal biopsy confirmed idiopathic membranous glomerulonephritis. She had persistent proteinuria of 6 g/day with hypoalbuminaemia despite angiotensin receptor blockade. Treatment with tacrolimus monotherapy led to remission of proteinuria, three months prior to conceiving again. She maintained remission with tacrolimus therapy in pregnancy, resulting in a successful birth outcome. CONCLUSIONS: Membranous glomerulonephritis can be successfully and safely managed with tacrolimus monotherapy during pregnancy. This provides an alternative immunosuppressant with a favourable side effect profile suitable for use in women planning a pregnancy when other immunosuppressive drugs should be avoided.
Authors: P Jungers; D Forget; M Henry-Amar; G Albouze; P Fournier; U Vischer; D Droz; L H Noël; J P Grunfeld Journal: Adv Nephrol Necker Hosp Date: 1986
Authors: Mary F Hebert; Songmao Zheng; Karen Hays; Danny D Shen; Connie L Davis; Jason G Umans; Menachem Miodovnik; Kenneth E Thummel; Thomas R Easterling Journal: Transplantation Date: 2013-04-15 Impact factor: 4.939
Authors: Jara Caro; Elena Gutiérrez-Solís; Jorge Rojas-Rivera; Irene Agraz; Natalia Ramos; Cristina Rabasco; Mario Espinosa; Alfonso Valera; Mónica Martín; Miguel Ángel Frutos; Lara Perea; Gema Fernández Juárez; Javier Ocaña; David Arroyo; Marian Goicoechea; Laura Fernández; Aniana Oliet; Yolanda Hernández; Ana Romera; Alfons Segarra; Manuel Praga Journal: Nephrol Dial Transplant Date: 2014-10-01 Impact factor: 5.992
Authors: D Huscher; K Thiele; E Gromnica-Ihle; G Hein; W Demary; R Dreher; A Zink; F Buttgereit Journal: Ann Rheum Dis Date: 2008-08-06 Impact factor: 19.103